Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner | 2024-02-28 19:13:18 | 5,698,091
864,487 | 6,562,578 | Form 4 |
Rhodes Jason P
Director | 2024-03-05 17:08:16 | 0
6,545,479 | 6,545,479 | Form 4 |
Forbion Capital Fund IV Cooperatief U.A.
10% Owner | 2021-02-16 06:38:52 | 6,131,079
0 | 6,131,079 | Form 13G |
RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner | 2024-04-04 19:04:18 | 5,213,661
0 | 5,213,661 | Form 13G |
MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner | 2024-02-12 16:06:32 | 3,451,303
0 | 3,451,303 | Form 13G |
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
Atlas Venture Opportunity Fund II L.P.
Atlas Venture Associates Opportunity II LP
Atlas Venture Associates Opportunity II LLC
10% Owner | 2024-03-05 17:07:00 | 1,458,691
847,388 | 2,306,079 | Form 4 |
VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner | 2023-02-10 16:31:31 | 2,220,034
0 | 2,220,034 | Form 13D |
Logos Global Management LP
10% Owner | 2023-02-14 15:53:47 | 2,150,000
0 | 2,150,000 | Form 13G |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner | 2020-09-23 18:56:45 | 1,608,785
0 | 1,608,785 | Form 4 |
Kersten Dirk
Director
10% Owner | 2024-01-11 16:31:55 | 0
1,428,571 | 1,428,571 | Form 4 |
Brumm Joshua T
CEO & President | 2024-03-12 21:56:20 | 754,536
0 | 754,536 | Form 4 |
Subramanian Romesh
Chief Scientific Officer
10% Owner | 2020-09-18 17:12:38 | 694,434
0 | 694,434 | Form 4 |
CureDuchenne Ventures LLC
10% Owner | 2020-09-23 19:05:52 | 602,972
0 | 602,972 | Form 4 |
HIGH SUSANNA GATTI
Chief Operating Officer | 2024-03-13 06:04:11 | 156,800
0 | 156,800 | Form 4 |
Beskrovnaya Oxana
Chief Scientific Officer | 2024-03-12 21:42:33 | 152,352
0 | 152,352 | Form 4 |
Farwell Wildon
Chief Medical Officer | 2024-03-12 21:58:16 | 150,560
0 | 150,560 | Form 4 |
Scalzo Richard William
SVP, Head of Finance & Admin. | 2024-03-12 21:57:40 | 129,138
0 | 129,138 | Form 4 |
McNeill Jonathan
Chief Business Officer | 2024-04-04 21:06:10 | 35,000
0 | 35,000 | Form 4 |
Stehman-Breen Catherine
Director | 2023-05-25 18:38:57 | 24,900
0 | 24,900 | Form 4 |
Lubner David Charles
Director | 2023-05-25 18:37:59 | 24,900
0 | 24,900 | Form 4 |
Incerti Carlo
Director | 2023-05-25 18:37:04 | 24,900
0 | 24,900 | Form 4 |
HURWITZ EDWARD
Director | 2023-05-25 18:36:49 | 24,900
0 | 24,900 | Form 4 |
Klein Lawrence Otto
Director | 2022-07-06 18:20:16 | 7222
0 | 7222 | Form 4 |
Cox John
CEO & President | 2024-04-04 21:07:38 | 5000
0 | 5000 | Form 3/A |